• Citer

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.

par Marechal, Raphaël ;Mackey, John R;Lai, Raymond;Demetter, Pieter ;Peeters, Marc;Polus, Marc;Cass, Carol E;Salmon, Isabelle ;Devière, Jacques ;Van Laethem, Jean-Luc
Référence Cancer, 116, 22, page (5200-5206)
Publication Publié, 2010-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
Auteur:	Marechal, Raphaël; Mackey, John R; Lai, Raymond; Demetter, Pieter; Peeters, Marc; Polus, Marc; Cass, Carol E; Salmon, Isabelle; Devière, Jacques; Van Laethem, Jean-Luc
Informations sur la publication:	Cancer, 116, 22, page (5200-5206)
Statut de publication:	Publié, 2010-11
Sujet CREF:	Anatomopathologie
	Médecine pathologie humaine
Mots-clés:	cancer
	deoxycytidine kinase
	gemcitabine
	pancreas
	surgery
MeSH keywords:	Adenocarcinoma -- drug therapy -- enzymology -- surgery
	Adult
	Aged
	Aged, 80 and over
	Chemotherapy, Adjuvant
	Combined Modality Therapy
	Deoxycytidine -- analogs & derivatives -- therapeutic use
	Deoxycytidine Kinase -- metabolism
	Disease-Free Survival
	Female
	Humans
	Male
	Middle Aged
	Pancreatic Neoplasms -- drug therapy -- enzymology -- metabolism -- mortality -- surgery
	Treatment Outcome
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	FLWIN
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0008-543X
	info:doi/10.1002/cncr.25303
	info:scp/78449295201
	info:pmid/20669326